logo

For the Inventor, By the Inventor

Gaithersburg, MD, United States of America

Bolin Qin

This inventor holds 8 USPTO granted patents and 4 published patent applications. Top assignees: In Ingredients, Inc., Fhg Corporation. Active years: 2012-2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Bolin Qin. Retrieved from https://idiyas.com/inventor/bolin-qin

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 8 

% Patents Active = 100.0

Average Co-Inventor Count = 2.6

ph-index = 1

Forward Citations = 5(Granted Patents)


Company Filing History:

goldMedal5 out of 9 
 
In Ingredients, Inc.
 patents
silverMedal3 out of 7 
 
Fhg Corporation
 patents

Years Active: 2012-2021

Loading Chart...
8 patents (USPTO):Explore Patents
1. 10894030 - Methods and compositions for the inhibition of the expression of PD-L1 in tumor cells (2021-01-19),
2. 10842774 - Inhibited expression of PD-L1 and enhanced expression of PD-1 (2020-11-24),
3. 10478418 - Inhibited expression of PD-L1 and enhanced expression of PD-1 (2019-11-19),
4. 10058579 - Dietary supplements containing extracts of cinnamon and methods of using same to promote enhanced sirtuin, cell and telomere integrity (2018-08-28),
5. 10039798 - Extracts of rosemary or hemerocallis fulva and methods of using same to promote circadian rhythm (2018-08-07),
6. 8613959 - Dietary supplements containing extracts of Nelumbo and processes of using same (2013-12-24),
7. 8445035 - Dietary supplements containing extracts of aronia and method of using same to promote weight loss (2013-05-21),
8. 8158683 - Dietary supplements containing extracts of aronia and methods of using same to promote weight loss (2012-04-17),

Title: Bolin Qin: Innovator in Cancer Treatment

Introduction

Bolin Qin is a prominent inventor based in Gaithersburg, MD (US). He has made significant contributions to the field of cancer treatment through his innovative patents. With a total of 8 patents, Qin's work focuses on methods and compositions that inhibit the expression of PD-L1 in tumor cells.

Latest Patents

One of his latest patents involves processes for decreasing the expression of a CD274 gene and/or a PD-L1 protein in subjects. This patent outlines the administration of a composition containing at least 0.5% of an active ingredient by weight, which includes cinnamtannin D1 and/or cinnamtannin B1. Another notable patent addresses the inhibition of PD-L1 expression while enhancing PD-1 expression. This process is aimed at treating autoimmune diseases by modulating gene expression levels in subjects.

Career Highlights

Bolin Qin has worked with several companies, including Ingredients, Inc. and FHG Corporation. His experience in these organizations has contributed to his expertise in developing innovative solutions for cancer treatment.

Collaborations

Throughout his career, Qin has collaborated with notable professionals such as Augustin T. Romero and Peter J. Miller. These collaborations have further enriched his research and development efforts.

Conclusion

Bolin Qin's contributions to cancer treatment through his innovative patents demonstrate his commitment to advancing medical science. His work continues to impact the field positively, paving the way for new therapeutic approaches.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…